NASDAQ:FLGT

20.75
0.11 (0.53%) 1d
0
WATCH
Fulgent Genetics
They do genetic testing for rare diseases and other applications. They rolled out many tests during Covid, which became their major source of revenue (88%). Flush with that cash, they bought a company in August 2021, a good long-term opportunity in cancer testing. They didn't rest on their laurels. However, the market sees Fulgent as a Covid stock and has dumped it. Analysts expect their earnings to vanish in 2023. Do you believe in the rest of their business to have faith in it. He doesn't see much downside, but there's nothing urgent here to make him buy. He wants to see their Q4 numbers before making a movie. They have net cash of $900 million.
biotechnology
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Fulgent Genetics(FLGT-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Fulgent Genetics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Fulgent Genetics(FLGT-Q) Frequently Asked Questions

What is Fulgent Genetics stock symbol?

Fulgent Genetics is a American stock, trading under the symbol FLGT-Q on the NASDAQ (FLGT). It is usually referred to as NASDAQ:FLGT or FLGT-Q

Is Fulgent Genetics a buy or a sell?

In the last year, there was no coverage of Fulgent Genetics published on Stockchase.

Is Fulgent Genetics a good investment or a top pick?

Fulgent Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Fulgent Genetics.

Why is Fulgent Genetics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Fulgent Genetics worth watching?

In the last year, there was no coverage of Fulgent Genetics published on Stockchase.

What is Fulgent Genetics stock price?

On 2024-04-24, Fulgent Genetics (FLGT-Q) stock closed at a price of $20.75.